NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Glioblastoma Multiforme

Countries: Taiwan

This single-arm, open-label, multicenter, observational study will evaluate the efficacy and safety of Avastin (bevacizumab) in patients with glioblastoma multiforme in first or second relapse. Data will be collected from eligible patients initiated on Avastin treatment according to local label for up to 3 years.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Adults patients, \>/= 18 years of age
* Histologically confirmed glioblastoma multiforme in first or second relapse

Exclusion Criteria:

* Patients not qualifying for Avastin treatment as per local label

Locations (3)

Kaohisung, Taiwan
Taipei, Taiwan
Taipei, Taiwan